1. Search Result
Search Result
Results for "

cd30

" in MedChemExpress (MCE) Product Catalog:

4

Inhibitors & Agonists

2

Inhibitory Antibodies

20

Recombinant Proteins

Recombinant Proteins Recommended:
Cat. No. Compare Product Name Species Source
  • HY-P70075

    rMuTumor necrosis factor receptor superfamily member 8/TNFRSF8, His; Tumor necrosis factor receptor superfamily member 8; cd30L receptor; Lymphocyte activation antigen cd30; cd30; Tnfrsf8

    Mouse HEK293
    CD30/TNFRSF8 Protein, the TNFSF8/CD30L receptor, critically regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B signaling, modulating gene expression and contributing to diverse cellular processes. Interactions with key signaling molecules (TRAF1, TRAF2, TRAF3, and TRAF5) underscore its significance in mediating essential intracellular pathways for cellular responses and regulatory functions. CD30/TNFRSF8 Protein, Mouse (263a.a, HEK293, His) is the recombinant mouse-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of CD30/TNFRSF8 Protein, Mouse (263a.a, HEK293, His) is 263 a.a., with molecular weight of 54-63 kDa.
  • HY-P701265

    TNFRSF8; cd30; D1S166E; Ki-1

    Human HEK293
    CD30/TNFRSF8, a receptor for TNFSF8/CD30L, regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B, modulating gene expression. Interactions with TRAF1, TRAF2, TRAF3, and TRAF5 indicate involvement in complex signaling networks. Engagement with TNFSF8 implies impact on immune responses and cellular homeostasis, emphasizing its significance in fundamental biological processes. FITC-Labeled CD30/TNFRSF8 Protein, Human (HEK293, Fc) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293, with His labeled tag. The total length of FITC-Labeled CD30/TNFRSF8 Protein, Human (HEK293, Fc) is 361 a.a., with molecular weight of 70-110 kDa.
  • HY-P70023

    rHuTumor necrosis factor receptor superfamily member 8/cd30, His; Tumor necrosis factor receptor superfamily member 8; cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; cd30; TNFRSF8

    Human HEK293
    CD30/TNFRSF8, a receptor for TNFSF8/CD30L, regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B, modulating gene expression. Interactions with TRAF1, TRAF2, TRAF3, and TRAF5 indicate involvement in complex signaling networks. Engagement with TNFSF8 implies impact on immune responses and cellular homeostasis, emphasizing its significance in fundamental biological processes. CD30/TNFRSF8 Protein, Human (HEK293, His) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of CD30/TNFRSF8 Protein, Human (HEK293, His) is 361 a.a., with molecular weight of 60-95 kDa.
  • HY-P78405

    cd153; cd30 Ligand; cd30L; cd30-L; cd30LGMGC138144; TNFSF8; cd30LG

    Human HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293, mFc) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal mFc-tag.
  • HY-P72354

    cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; TNFRSF8

    Human HEK293
    CD30/TNFRSF8, a receptor for TNFSF8/CD30L, regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B, modulating gene expression. Interactions with TRAF1, TRAF2, TRAF3, and TRAF5 indicate involvement in complex signaling networks. Engagement with TNFSF8 implies impact on immune responses and cellular homeostasis, emphasizing its significance in fundamental biological processes. CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-6*His, C-Avi labeled tag. The total length of CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His-Avi) is 361 a.a., with molecular weight of 60-90 kDa.
  • HY-P75639

    TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8

    Rat HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in rat contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30L Protein, Cynomolgus (HEK293, Fc) is 172 amino acids in length (Q66-D237) and is expressed in the HEK293 cells with tag free.
  • HY-P78406

    cd30; cd30KI-1; cd30L receptor; TNFRSF8; D1S166EKi-1; cd30KI-1

    Human HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293, His-Avi) is 361 amino acids in length (F19-K379) and is expressed in the HEK293 cells with C-terminal Avi- and His-tag.
  • HY-P75640

    TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8

    Rat HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in rat contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Rat (HEK293, Fc) is 172 amino acids in length (Q66-D237) and is expressed in the HEK293 cells with a N-terminal hFc-tag.
  • HY-P700036AF

    soluble cd30 Ligand; Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG

    Human E. coli
    CD30 ligand/TNFSF8 protein is a cytokine that specifically binds to TNFRSF8/CD30 and acts as a potent inducer of T cell proliferation. As a homotrimer, this ligand plays a crucial role in regulating T cell activation and growth, contributing to the dynamic coordination of immune responses. Animal-Free CD30 Ligand/TNFSF8 Protein, Human (His) is the recombinant human-derived animal-FreeCD30 Ligand/TNFSF8 protein, expressed by E. coli , with C-His labeled tag. The total length of Animal-Free CD30 Ligand/TNFSF8 Protein, Human (His) is 172 a.a., with molecular weight of ~20.57 kDa.
  • HY-P700433

    rHuTumor necrosis factor receptor superfamily member 8/cd30, His; Tumor necrosis factor receptor superfamily member 8; cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; cd30; TNFRSF8

    Human HEK293
    CD30/TNFRSF8, a receptor for TNFSF8/CD30L, regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B, modulating gene expression. Interactions with TRAF1, TRAF2, TRAF3, and TRAF5 indicate involvement in complex signaling networks. Engagement with TNFSF8 implies impact on immune responses and cellular homeostasis, emphasizing its significance in fundamental biological processes. CD30/TNFRSF8 Protein, Human (HEK293, N-His, C-Myc) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293, with C-Myc, N-10*His labeled tag. The total length of CD30/TNFRSF8 Protein, Human (HEK293, N-His, C-Myc) is 361 a.a., with molecular weight of 43.5 kDa.
  • HY-P77321

    TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8

    Cynomolgus HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in cynomolgus contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30L Protein, Cynomolgus (HEK293, Fc) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal hFc-tag.
  • HY-P77322

    TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8

    Cynomolgus HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in cynomolgus contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30L Protein, Cynomolgus (HEK293, His) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal His-tag.
  • HY-P76224

    Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG

    Human HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with tag free.
  • HY-P700673

    cd30; cd30KI-1; cd30L receptor; TNFRSF8; D1S166EKi-1; cd30KI-1

    Cynomolgus HEK293
    CD30/TNFRSF8 Protein exhibits an absence of conserved residue(s) crucial for the propagation of feature annotation. CD30/TNFRSF8 Protein, Cynomolgus (HEK293, C-His) is the recombinant cynomolgus-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD30/TNFRSF8 Protein, Cynomolgus (HEK293, C-His) is 368 a.a., with molecular weight of 75-105 kDa.
  • HY-P76225

    Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG

    Human HEK293
    CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293, Fc) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal hFc-tag.
  • HY-P700434

    Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG

    Human HEK293
    CD30 ligand/TNFSF8 protein is a cytokine that specifically binds to TNFRSF8/CD30 and acts as a potent inducer of T cell proliferation. As a homotrimer, this ligand plays a crucial role in regulating T cell activation and growth, contributing to the dynamic coordination of immune responses. CD30 Ligand/TNFSF8 Protein, Human (HEK293, N-His) is the recombinant human-derived CD30 Ligand/TNFSF8 protein, expressed by HEK293 , with N-6*His labeled tag. The total length of CD30 Ligand/TNFSF8 Protein, Human (HEK293, N-His) is 172 a.a., with molecular weight of 21.8 kDa.
  • HY-P75421

    cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen

    Human HEK293
    CD30/TNFRSF8, a receptor for TNFSF8/CD30L, regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B, modulating gene expression. Interactions with TRAF1, TRAF2, TRAF3, and TRAF5 indicate involvement in complex signaling networks. Engagement with TNFSF8 implies impact on immune responses and cellular homeostasis, emphasizing its significance in fundamental biological processes. CD30/TNFRSF8 Protein, Human (HEK293, hFc) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CD30/TNFRSF8 Protein, Human (HEK293, hFc) is 361 a.a., with molecular weight of ~65.2 kDa.
  • HY-P75422

    cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen

    Human HEK293
    CD30/TNFRSF8, a receptor for TNFSF8/CD30L, regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B, modulating gene expression. Interactions with TRAF1, TRAF2, TRAF3, and TRAF5 indicate involvement in complex signaling networks. Engagement with TNFSF8 implies impact on immune responses and cellular homeostasis, emphasizing its significance in fundamental biological processes. CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His) is 361 a.a., with molecular weight of ~39.9 kDa.
  • HY-P76221

    cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen

    Mouse HEK293
    CD30/TNFRSF8 Protein, the TNFSF8/CD30L receptor, critically regulates cellular growth and lymphoblast transformation. It activates NF-kappa-B signaling, modulating gene expression and contributing to diverse cellular processes. Interactions with key signaling molecules (TRAF1, TRAF2, TRAF3, and TRAF5) underscore its significance in mediating essential intracellular pathways for cellular responses and regulatory functions. CD30/TNFRSF8 Protein, Mouse (258a.a, HEK293, His) is the recombinant mouse-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD30/TNFRSF8 Protein, Mouse (258a.a, HEK293, His) is 258 a.a., with molecular weight of ~26.6 KDa.
  • HY-P76792

    cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen

    Cynomolgus HEK293
    CD30/TNFRSF8 Protein exhibits an absence of conserved residue(s) crucial for the propagation of feature annotation. CD30/TNFRSF8 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD30/TNFRSF8 Protein, Cynomolgus (HEK293, His) is 194 a.a., with molecular weight of 37-41 kDa.

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: